EQUINOXYS INC. - CURRENTLY, THE FDA PERFORMS THIS REVIEW USING A MACRO-ENABLED MICROSOFT EXCEL WORKBOOK. THE FILE IS HARD TO MAINTAIN AND CHALLENGING TO RUN BASED ON FILE SIZE RESTRICTIONS. THE CURRENT SOLUTION DOES NOT ALLOW FOR STREAMLINED REVIEWS AND MAY IMPACT E

PIID: 75F40123F19021
Effective Date: Jul 5, 2023End Date: Closed on Jun 30, 2024
Award $
$1.7M
Vendor
EQUINOXYS INC.
NAICS
541513

Key Details

Dollars Obligated
$1.7M
Base & All Options
$1.7M
Awarding Sub-Agency
Food and Drug Administration
NAICS Code
541513
Parent IDIQ (PIID)
75F40118A10047
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
MD

Description

CURRENTLY, THE FDA PERFORMS THIS REVIEW USING A MACRO-ENABLED MICROSOFT EXCEL WORKBOOK. THE FILE IS HARD TO MAINTAIN AND CHALLENGING TO RUN BASED ON FILE SIZE RESTRICTIONS. THE CURRENT SOLUTION DOES NOT ALLOW FOR STREAMLINED REVIEWS AND MAY IMPACT E

Context & Analysis

Department of Health and Human Services obligated $1,671,906.19 to EQUINOXYS INC. for currently, the fda performs this review using a macro-enabled microsoft excel workbook. the file is hard to maintain and challenging to run based on file size restrictions. the current solution does . The award is classified under NAICS 541513. Competition extent: full and open competition. Performance is located in MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541513 — related awards are listed below.

Contractor Information

Contractor: EQUINOXYS INC.
UEI: KB8BBLEREKL6

Stay Updated

Get notified about new opportunities matching your interests.

Related